Buy These 3 Oberweis Mutual Funds for Strategic Allocation

Why It Matters

These funds combine strong recent performance with low fees, offering investors a cost‑effective way to add diversified small‑cap exposure and international growth potential to their portfolios.

Key Takeaways

• OBSOX yields 14.4% 3‑yr return, low fees.
• OBIOX delivers 15.6% 3‑yr return, international focus.
• OBEGX offers 12.5% 3‑yr return, sub‑$1B cap.
• All three hold Zacks Rank #1 or #2.
• Minimum investment $5,000, expense ratios below category.

Pulse Analysis

Oberweis Asset Management, a Chicago‑based independent firm founded in 1989, has built a reputation for deep fundamental research across micro‑, small‑ and mid‑cap equities. Leveraging analyst teams in New York, London and Hong Kong, the firm seeks undervalued companies poised for rapid growth, whether they are navigating transitional phases or riding long‑term industry tailwinds. This research‑driven approach underpins the three highlighted funds, giving investors confidence that portfolio managers are not merely chasing market trends but targeting sustainable value creation.

The three funds each deliver compelling risk‑adjusted returns. OBSOX, concentrated in Russell 2000 small‑caps, posted a 14.4% three‑year annualized return with a modest 1.25% expense ratio, earning a Zacks #1 rank. OBIOX expands the horizon to non‑U.S. equities, achieving a 15.6% three‑year return despite a slightly higher 1.35% fee, also ranked #1. OBEGX, focused on sub‑$1 billion global companies, generated a 12.5% three‑year return and carries a 1.45% expense ratio, earning a Zacks #2. All three meet a low $5,000 entry point, making them attractive for both retail and institutional investors seeking diversified exposure.

In today’s market, where large‑cap valuations are stretched and fee sensitivity is rising, low‑cost small‑cap and international funds can enhance portfolio resilience. Oberweis’s disciplined valuation framework offers a buffer against volatility, while the strong historical performance suggests the funds can capture upside in emerging growth segments. Investors should consider these funds as core holdings for long‑term growth, balancing them with broader asset classes to mitigate concentration risk. However, the inherent volatility of small‑cap and international markets warrants a measured allocation aligned with individual risk tolerance.